Alanine racemase (Alr) is an essential enzyme in most bacteria; however, some species (e.g. Listeria monocytogenes) can utilize D-amino acid transaminase (Dat) to generate D-alanine, which renders Alr non-essential. In addition to the conflicting reports on gene knockout of alr in Mycobacterium smegmatis, a recent study concluded that depletion of Alr does not affect the growth of M. smegmatis. In order to get an unambiguous answer on the essentiality of Alr in Mycobacterium tuberculosis and validate it as a drug target in vitro and in vivo, we have inactivated the alr gene of M. tuberculosis and found that it was not possible to generate an alr knockout in the absence of a complementing gene copy or D-alanine in the growth medium. The growth kinetics of the alr mutant revealed that M. tuberculosis requires very low amounts of Dalanine (5-10 mg ml 
INTRODUCTION
The presence of drug-resistant bacteria poses a serious challenge to treatment of tuberculosis (TB) as a significant number of bacteria are becoming resistant to currently used drugs. Multidrug resistant and extensively drug resistant strains of Mycobacterium tuberculosis, which are resistant to first-and second-line TB drugs, are evolving all over the world (Chan & Iseman, 2008) . As TB is the major disease prevalent in immunocompromised HIV patients (Wells et al., 2007) , the AIDS epidemic has thrown up additional challenges to treat this ancient scourge of mankind. Though a number of promising M. tuberculosis inhibitors have been developed (Ginsberg, 2010) , none has been advanced enough to be used clinically. Similarly, efforts to design novel vaccines are under way and a number of candidate vaccines are being tested in clinical trials (Kaufmann et al., 2010) . Development of good genetic tools and the availability of genome sequences of M. tuberculosis (Cole et al., 1998) are expected to help in the validation of new M. tuberculosis proteins as drug or vaccine candidates.
D-Alanine (D-ala) is a critical component of peptidoglycan and alanine racemase (Alr), the enzyme responsible for racemization of L-ala into D-ala (Fig. 1) , is an essential enzyme in most bacteria (Hols et al., 1997; Steen et al., 2005) . However, a few bacteria (e.g. Listeria monocytogenes) have the capacity to survive in the absence of Alr by virtue of their ability to convert L-ala into D-ala using D-amino acid aminotransferase (Dat). Thus, L. monocytogenes mutants lacking Alr are healthy, but double mutants (alr, dat) are dependent on D-ala for growth (Thompson et al., 1998) . Amongst Gram-negative bacteria, Alr has been well characterized in Escherichia coli and Salmonella typhimurium. Both these organisms carry two isoforms of alanine racemase (Alr and DadX) and it has been demonstrated that inactivation of individual genes does not lead to D-ala dependency. However, inactivation of both the genes together leads to D-ala auxotrophy (Wasserman et al., 1983) . Amongst the Gram-positives, Alr has been shown to be essential for the survival of Bacillus and Lactobacillus species (Hols et al., 1997; Steen et al., 2005) . D-Cycloserine (DCS), which is a second-line anti-TB drug, is known to interfere with peptidoglycan synthesis by inhibiting Alr and D-ala-D-ala ligase, Ddl (Strych et al., 2001; Bruning et al., 2011) . From the published literature, it is not clear whether bacterial killing results from inhibition of both the targets or whether inhibition of either of these can also cause growth inhibition or cell death. The fact that the overexpression of either Alr or Ddl in Mycobacterium smegmatis leads to an increase in the MIC of DCS suggests that this drug kills mycobacteria by inhibiting both Alr and Ddl (Cáceres et al., 1997; Feng & Barletta, 2003) . The ability of D-ala-D-ala to complement a DCSsupersensitive temperature-sensitive Ddl mutant of Staphylococcus aureus (Kurokawa et al., 2009 ) suggested that either Alr or Ddl or both the proteins are targeted by DCS. In a nuclear magnetic resonance-based metabolomics study it was shown that DCS inhibits multiple targets and was suggested that Ddl could be the primary target of DCS in mycobacteria (Halouska et al., 2007) . As DCS-mediated inhibition of bacterial growth is reversed in the presence of D-ala in the medium (Zygmunt, 1963) , DCS might kill bacteria by inhibiting Alr alone. Recently reported inhibitors of Alr inhibited the growth of M. tuberculosis (Anthony et al., 2011) . However, nonreversibility of inhibition in the presence of D-ala showed that the cellular killing could result from off-target effects.
The genetic approach of proving essentiality of Alr has yielded ambiguous results in M. smegmatis. An initial study concluded that Alr activity is not required for the survival of M. smegmatis and there could be an alternative pathway for the synthesis of D-ala in M. smegmatis (Chacon et al., 2002) . However, in a later study by Milligan et al. (2007) , it was shown that deletion of the alr gene results in D-ala auxotrophy, thus ruling out the possibility of the existence of an alternative pathway in M. smegmatis. Furthermore, in a very recent report (Wei et al., 2011) , it was shown that depletion of intracellular Alr by controlled proteolysis did not affect the growth of M. smegmatis, which suggested that Alr is not a critical enzyme in this organism. In order to gain a better understanding of the role of Alr in the physiology of M. tuberculosis and validate Alr as a drug target, we have inactivated the alr gene and studied the mutant phenotype in vitro, in macrophages and in mice.
METHODS
Plasmids and strains. The plasmids and the strains used in this study are listed in Table 1 .
Statistical analysis. This was performed using GraphPad Prism software. ) was added to the culture medium when required.
Gene knockout plasmid constructs. The plasmids used in this study are listed in Table 1 . The constructs used for gene knockout (KO) of alr were outsourced to Bangalore Genei (India). The recombination substrate for creating a deletion in the alr gene of M. tuberculosis consisted of 682 bp of the region upstream of alr, 147 bp of alr followed by a 223 bp deletion in alr which rendered the remaining 840 bp alr out of frame. This DNA fragment was cloned into ScaI-SspI sites of a suicide vector, pGOAL19 (Parish & Stoker, 2000) . The resulting construct was designated pAZI0240. For making the complementation construct, the alr gene (Rv3423c) was amplified from M. tuberculosis genomic DNA by PCR using high-fidelity Taq DNA polymerase (Phusion, Finnzyme). The amplified PCR product was cloned into EcoRI-HindIII sites of the integrating mycobacterial expression vector pAZI272 (Awasthy et al., 2009) . The sequences of the cloned DNA fragments were confirmed by sequencing (Microsynth).
DNA amplification by PCR. The single cross-over (SCO) and double cross-over (DCO) recombinants in M. tuberculosis were screened by colony PCR as described previously (Awasthy et al., 2009) . Denaturation and extension reactions were performed at 94 and 72 uC, respectively, for 30 s each. The annealing temperature and extension time for each PCR was decided by considering the melting temperature of the primer pair and length of the PCR product, respectively. The sequences of primers used for PCR amplification were as follows: 366, 59-TTTGGTCTTCAGCTAGATCA-39; 367, 59-AAAGCCAAACGACACGACAG-39; 368, 59-GCAACAGTTCGA-CGAGTTGG-39.
Southern blotting. Genomic DNA from the wild-type and alr KOs of M. tuberculosis were digested with XmaI and XhoI and separated by electrophoresis on 0.8 % agarose gels. A DNA fragment amplified by PCR encompassing the upstream region and 59 end of alr, which was labelled with fluorescein by random prime labelling (Roche), was used as a probe. DNA transfer, hybridization and washings were performed according to the protocol provided by the manufacturer (GE, Amersham). The bound probes were detected by horseradish peroxidase-conjugated anti-fluorescein antibodies (1 : 2000 dilution) using chemiluminescence.
MIC reversal with D-ala or D-ala-D-ala. The MIC of DCS on M. tuberculosis was determined by using the Alamar blue method using microtitre plates (Franzblau et al., 1998) . In order to look for reversal of the DCS effect, the MIC experiment was set up with cultures containing increasing concentrations of D-ala (0, 2, 5, 10, 20, 50 and 100 mg ml 21 ) or D-ala-D-ala (up to 1 mg ml 21 ). The plates were incubated for 6 days at 37 uC. Alamar blue dye was added to the culture at the end of day 6 and the plates were further incubated for 24 h. The change in dye colour was noted at the end of day 7.
Growth and survival kinetics of M. tuberculosis alr KO in vitro.
For growth studies in liquid culture, the alr mutant culture was grown in the presence of 50 mg D-ala ml 21 , diluted in fresh 7H9 medium containing increasing concentrations of D-ala or D-ala-D-ala and OD 600 was measured. For growth kinetics on agar plates, the mutant culture was grown up to OD 600 0.8 in the presence of 50 mg D-ala ml 21 , washed and resuspended in plain 7H9 medium. Appropriate culture dilutions were plated on plates containing 0-20 mg D-ala ml 21 to obtain isolated colonies. The plates were incubated at 37 uC and colonies were counted after 3 and 8 weeks of incubation. To study the survival kinetics of the alr mutant in the absence of D-ala, the mutant culture grown in the presence of 10 mg D-ala ml 21 was washed free of extracellular D-ala and resuspended in plain 7H9. The culture was incubated on a roller for 7 days and aliquots were monitored for viability by plating various dilutions of the culture on 7H9 containing 10 mg D-ala ml 21 . The colonies were counted after incubation for 1 month at 37 uC.
Growth of M. tuberculosis H37Rv and alr KO mutant in macrophages. Intracellular infection and survival kinetics of mycobacterial strains were investigated in IFN-c-activated primary cultures of bone marrow-derived macrophages (BMDM) in a 24-well plate format. Briefly, bone marrow cells were flushed from mouse femurs and cultured in complete RPMI 1640 medium (Gibco laboratories) with 20 % L929-conditioned medium for 5 days. The macrophage monolayers were activated by addition of 25 ng recombinant IFN-c ml 21 (Sigma) for 48 h. Activated and washed BMDM monolayers were used for infection. The monolayers were infected with M. tuberculosis H37Rv and alr KO mutant strains individually at an m.o.i. of 1 : 10. Two hours post-infection, the monolayers were washed with PBS and replaced with RPMI 1640 medium and the monolayers were incubated for 7 days. On days 0, 3 and 7 the monolayers were lysed and the lysates were plated on 7H9+10 mg D-ala ml 21 . Before lysing, the viability of the cells was assessed microscopically by observing the adherence and intactness of the monolayers. Plate wells with more than 90 % intact cells were processed further.
Mouse infection. The animal usage and experimental protocols were approved by the Institutional Animal Ethics Committee, registered with the government of India (registration no. CPCSEA 99/5). To infect BALB/c mice by the intravenous route, the frozen bacterial samples were thawed, centrifuged, washed in PBS and diluted appropriately in cold, sterile PBS. The animals were infected with the wild-type or mutant M. tuberculosis strains to obtain 10 5 c.f.u. per animal. After infection, the animals were sacrificed at an interval of 1 week and the bacterial counts present in the organs were determined by plating the lung and spleen homogenates on 7H11 agar supplemented with D-ala (10 mg ml 21 )
RESULTS
alr gene of M. tuberculosis can only be inactivated in the presence of an extra copy of alr or D-ala in the growth medium
To determine whether Alr is essential for the survival of M. tuberculosis, we decided to inactivate the alr gene by a twostep homologous recombination procedure involving an SCO followed by a DCO recombination event as described previously (Awasthy et al., 2009; Parish & Stoker, 2000) . In order to avoid any polar effects on downstream genes, inactivation of alr was attempted by introducing a markerless deletion as described in Methods. The gene KO was performed under the following three conditions: 1) in the presence of single copy of the alr gene (wild-type M. tuberculosis), 2) in the presence of two copies of alr (merodiploid) and 3) in the presence of D-ala (100 mg ml 21 ), the reaction product of Alr, in the growth medium. The ability to obtain a gene KO only in the presence of an additional copy of the gene in the merodiploid strain or Dala in the medium was taken as evidence of essentiality of the gene. The third condition (D-ala in the medium) was expected to provide an opportunity to study the strain's phenotype in the absence of D-ala in vitro and in macrophages and mice.
After electroporation of pAZI0401 into M. tuberculosis, an SCO recombinant (hyg + , sacB + ; alr/SCO) was identified by PCR to detect hyg and sacB genes (data not shown) and by primers corresponding to the alr locus as shown in Fig. 2(b) . alr/SCO was further used for obtaining DCO recombinants as described previously (Awasthy et al., 2009) . Briefly, alr/SCO was grown in the absence of hygromycin for 3 weeks and subsequently plated on 7H9 plates containing 2 % sucrose. The colonies growing in the presence of sucrose were screened for the loss of the plasmid by PCR amplification of hyg and sacB genes (data not shown). In the wild-type M. tuberculosis background, out of 177 colonies screened from sucrose plates, 11 had not undergone recombination and the remaining 166 were found to have lost the plasmid (hyg 2 , sacB 2 ; 94 % recombination efficiency); however, all had retained the wild-type copy of the gene indicating that inactivation of the alr gene leads to loss of viability. Following a similar procedure, we screened for the presence of KO colonies amongst DCO recombinants obtained from a merodiploid strain (alr/SCO with the alr gene on the att site). It was found that 10 of 66 DCOs (hyg 2 , sacB 2 ) were carrying the deleted copy of the gene, proving that when two copies of alr are present in the organism, it is possible to inactivate one of them. Next, we attempted inactivation of alr in the presence of D-ala (100 mg ml
21
). PCR screening of 88 colonies from sucrose plates for the loss of plasmid showed that 92 % had lost the plasmid (hyg 2 , sacB 2 ) by a DCO event, which showed that the recombination frequency of the cultures grown in the absence and the presence of D-ala was similar. After screening colonies by gene-specific primers, it was found that 13 % of the DCO colonies had a deleted copy of the gene in the chromosome, while the remaining had the wild-type copy of alr. This showed that it was possible to obtain a KO of alr provided the cells had access to D-ala. The inactivation of the alr gene in one of the DCO recombinants was confirmed by PCR (Fig. 2a, b) and by Southern blotting (Fig. 2c) . The observation that alr can only be inactivated in the presence of either an extra copy of alr or D-ala in the growth medium suggested that alr is an essential gene in M. tuberculosis. 
M. tuberculosis requires a very small amount of D-ala for growth
As seen in Fig. 3(a) there was no visible growth in liquid cultures of the Dalr mutant lacking D-ala, while cultures containing 5 mg D-ala ml 21 showed poor growth. Addition of more than 10 mg D-ala ml 21 to the medium did not make any difference to the growth rates, showing that 10 mg ml 21 is sufficient for optimum growth of the mutant strain. Interestingly, D-ala-D-ala, the end product of the pathway, was also able to support the growth of the Dalr mutant. However, it required a much higher concentration of D-ala-D-ala (500 mg ml 21 ) to support optimum growth (Fig. 3b) , which could be because of poor uptake of the dipeptide by the cells. This is the first report of D-ala-D-ala supporting the growth of an auxotrophic mutant of a mycobacterial species.
As seen in Fig. 3(c) , the agar plates containing 10 and 20 mg D-ala ml 21 showed similar c.f.u. at 3 and 8 weeks of incubation. In plates supplemented with 5 mg D-ala ml 21 , the number of colonies after 3 weeks was significantly less (P50.0004) than on plates containing 10 or 20 mg D-ala ml
21
, but by 8 weeks, the bacterial counts on all three concentrations of D-ala were found to be very similar. Under similar conditions, in plates containing 2 mg D-ala ml 21 a significant increase in c.f.u. was seen after 8 weeks (from 10 4 to 10 6 c.f.u. ml 21 , P50.0007). A further increase in c.f.u. was not seen by incubating the plates beyond 8 weeks. The data indicate that 5-10 mg D-ala ml 21 is the optimum amount of D-ala required for growth on agar. Interestingly, on plates without D-ala, no colonies could be seen at 3 weeks, but there was a significant number of small colonies by 8 weeks (Fig. 3c) The colonies picked up from the plate without D-ala and replated onto increasing concentrations of D-ala did not show any colonies in the absence of D-ala (data not shown), indicating that the growth on the plate with no D-ala in the earlier experiment was because of carry over of the D-ala pool present inside (Thompson et al., 1998; Palumbo et al., 2004; Milligan et al., 2007) . This suggests that, compared with other bacteria, M. tuberculosis requires very small amounts of Dala for growth.
Depletion of intracellular D-ala pool leads to cell death of M. tuberculosis
Since our data showed that M. tuberculosis requires small amounts of D-ala for growth, does this mean that depletion of the intracellular D-ala pool will only lead to cessation of cell growth or can it result in loss of viability? To resolve this, the Dalr mutant was incubated without D-ala for 7 days and the viability was determined by measuring c.f.u. on 7H9 containing 10 mg D-ala ml
21
. As shown in Fig.  3(d) , in the Dalr mutant, there was a continuous drop in c.f.u. over a period of 7 days. As expected, the Dalr culture supplemented with D-ala or complemented with alr, and the wild-type M. tuberculosis strains showed an increase in c.f.u. in the first week, after which the c.f.u. remained constant. Thus, it is clear that depletion of the D-ala pool in M. tuberculosis leads to death of the cells.
An Alr mutant of M. tuberculosis is defective for survival in macrophages
In order to assess the role of D-ala in survival of M. tuberculosis inside macrophages, the survival of the Dalr mutant was studied in BMDM cells made immunecompetent by activation with gamma-interferon. As seen in Fig. 4 , in the wild-type there was small increase in c.f.u. on day 3 followed by no change in c.f.u. till day 7, whereas the Dalr mutant showed 70 and 89 % reduction in c.f.u. by day 3 and day 7, respectively. The reduction in the c.f.u. observed with the Dalr mutant was statistically significant (P50.0008). Thus, D-ala is required for intracellular survival of M. tuberculosis. This finding is consistent with the results of Chacon et al. (2009) where an M. smegmatis mutant was used. As there was no net increase in the number of wild-type bacteria inside the macrophages during this time period, the presence of D-ala is probably required to maintain the integrity of the cell wall.
An Alr mutant of M. tuberculosis is defective for survival in mice
The D-ala-requiring mutant of M. tuberculosis is expected to face absolute shortage of D-ala inside the animals since the eukaryotic host tissues lack D-amino acids. As seen in Fig. 5 , both the wild-type and mutant M. tuberculosis were able to establish infection in mice, though the c.f.u. of Dalr seen in lungs and spleen of mice was ten times less than that of wild-type bacteria. Since the c.f.u. of the mutant and the wild-type H37Rv inoculated into the mice was the same, the lesser number of c.f.u. obtained on day 1 from lungs and spleen of mice infected with the Dalr mutant indicates that the absence of D-ala probably interferes with establishing infection. The growth profile of the wild-type bacteria showed that after a small drop in the number of c.f.u., there was a gradual increase in the number of bacteria in lungs while the c.f.u. counts in spleen did not change till day 63 (Fig. 5) . On the other hand, the Dalr mutant showed a more than 2-log 10 reduction in the bacterial counts obtained from lungs during the first week (Fig. 5a) . Thereafter, no further drop in c.f.u. was observed. Overall, the wild-type strain showed a 1.2-log 10 c.f.u. increase by day 63, whereas the mutant strain showed a reduction of 2.1-log 10 c.f.u. during this period. Though at a slower rate than that in lungs, a continuous drop in c.f.u. was seen in samples obtained from the spleen till day 21 (Fig. 5b) . Bacterial numbers in the wild-type strain did not increase from day 1 to day 63, whereas the mutant strain showed a 1.0-log 10 reduction in c.f.u. by day 63. After a steady decline in c.f.u. to day 21, there was curiously an increase in c.f.u. by day 28, which is unexplainable at this time. There was no significant change in c.f.u. between days 28 and 63. In order to have better confidence in the data, we performed statistical analysis by normalizing the c.f.u. of the wild-type and the mutant. This was done by increasing the c.f.u. of the mutant in lungs and spleen at all time points by the c.f.u. difference seen between the wildtype and the mutant at the beginning of the infection (i.e. 1.18-log 10 in lungs and 1.21-log 10 in spleen). Even after the normalization, the reduction in c.f.u. of the mutant in the lungs and the spleen was highly significant. , 1997; Feng & Barletta, 2003) , indicating dual target inhibition by DCS. Reversal of growth inhibition by supplementing with the product of the target enzyme is one way of proving the mechanism of action of an inhibitor. We hypothesized that if killing of M. tuberculosis by DCS was because of inhibition of both Alr and Ddl or if Alr was non-essential, then addition of D-ala will have either a partial effect or no effect on DCSmediated inhibition of M. tuberculosis. As seen in Table 2 , the addition of D-ala was able to reverse the DCS inhibition as the MIC changed from 8 mg ml 21 in the absence of D-ala to 128 mg ml 21 in the presence of 100 mg D-ala ml
21
. Addition of L-ala (up to 1000 mg ml 
DISCUSSION
In target-based drug discovery the compound leads are optimized on a single target and thus, it is crucial to confirm that a particular target (e.g. Alr) is essential and inhibition of the target alone will lead to suppression of mycobacterial growth. The essentiality of a target can be determined by either genetic means or the action of a specific inhibitor. DCS inhibits both Alr and Ddl proteins in vitro (Bruning et al., 2011) , which makes it difficult to decipher whether inhibition of either of these proteins individually will lead to growth inhibition. Studies based on overexpression of Alr or Ddl (Cáceres et al., 1997; Feng & Barletta, 2003) , reversal of DCS inhibition in the presence of D-ala in various bacteria (Wijsman, 1972) and a metabolomics approach in M. smegmatis (Halouska et al., 2007) suggest that killing of bacteria by DCS could be mediated through inhibition of either Alr or Ddl.
We have shown that either D-ala or D-ala-D-ala can reverse the effect of DCS inhibition in M. tuberculosis. Complete reversal of DCS-driven inhibition by D-ala alone suggests that, as proposed previously (Halouska et al., 2007) , Ddl is not the primary target of DCS in mycobacteria and inhibition of Alr contributes significantly towards killing by DCS. If DCS was killing mycobacteria by inhibiting Ddl alone, then D-ala alone would not be able to reverse the DCS effect as inhibition of Ddl would deprive the cell of Dala-D-ala which would lead to inhibition of cell growth.
The dependency of the alr mutant on D-ala, coupled with the absence of D-amino acid transaminase (Dat), confirms that Alr activity is essential for the survival of M. tuberculosis. In this respect, the mycobacterial mutants behave like many known alr mutants of bacteria such as E. coli, S. typhimurium, Lactococcus lactis and Lactobacillus plantarum (Wasserman et al., 1983; Hols et al., 1997; Steen et al., 2005) . Depletion of intracellular D-ala pools in alr mutants of E. coli, Bacillus subtilis and Lactobacillus plantarum has been shown to result in death of the cells (Wijsman, 1972; Heaton et al., 1988; Palumbo et al., 2004) .
The amount of D-ala required for the optimum growth of M. tuberculosis (5 mg ml
21
) is the lowest amongst the bacteria (Thompson et al., 1998; Palumbo et al., 2004; Milligan et al., 2007) and is almost ten times less than the amount of other amino acids required for optimum growth of M. tuberculosis (Awasthy et al., 2009) . The exact reason for this low requirement of D-ala is not clear, though it can be speculated that it might reflect the poor rate of peptidoglycan biosynthesis because of the very slow growth rate of M. tuberculosis.
The low requirement of D-ala is also reflected in the poor catalytic activity of recombinant mycobacterial Alr in vitro, compared with Alr from other bacterial species (Strych et al., 2001) . In spite of the low need for D-ala in M. tuberculosis, depletion of the intracellular pool not only leads to growth stasis but also causes cell death, indicating the possibility of obtaining bactericidal inhibitors with this target. This finding is consistent with the observations made with another cell wall target, InhA, whose depletion or inhibition leads to killing of bacteria (Vilchèze et al., 2000) . However, as suggested by target depletion experiments (Wei et al., 2011) , only a potent inhibitor of Alr is expected to inhibit mycobacterial growth. Availability of the crystal structure of M. tuberculosis Alr offers great opportunity for designing novel inhibitors of this essential enzyme (LeMagueres et al. 2005) . Looking at the phenotype of the alr mutant in mice, in which the depletion of the bacterial D-ala pool leads to a rapid loss of viability initially, followed by persistence of the remaining bacteria for several days, we are prompted to predict that the prospective Alr inhibitors, like other cell wall inhibitors (e.g. INH), might show early bactericidal activity, but could be poor in sterilizing activity (Mitchison, 2000) .
Bacterial mutants requiring D-ala for growth have been found to be attenuated for virulence in animal studies (Thompson et al., 1998 ). An L. monocytogens alr dat double mutant has been used as a vaccine candidate and shown significant protection against the wild-type strain of L. monocytogenes. Though the persisting nature of the alr mutant in mice does not bode well for obtaining inhibitors with sterilizing activity, the same feature can be utilized in designing a vaccine against TB. The attenuated nature of the alr mutant coupled with its ability to survive for long periods of time inside mice suggests that it could be a good vaccine candidate. However, more studies are required to prove this point.
